left main

EuroPCR 2024 | DOCTORS-LM Trial: CTO Optimizes Stent Outcomes in Left Main Disease?

The aim of this randomized open study was to determine whether CTO guided left main percutaneous coronary intervention (PCI) is superior to fluoroscopy guided PCI, using fractional flow reserve (FFR) after stenting. The secondary outcomes were procedural success (successful implantation, malposition, edge dissection or stent collapse) and major adverse cardiovascular events (MACE) at one year.<a href="https://solaci.org/en/2024/05/17/europcr-2024-doctors-lm-trial-cto-optimizes-stent-outcomes-in-left-main-disease/" title="Read more" >...</a>

La ATC es una alternativa válida en el TCI

Physiologically Significant Obstructions in the Left Main Coronary Artery: Revascularizing vs. Deferring

Most randomized studies on revascularization in stable coronary artery disease exclude left main coronary artery disease (LMCAD). One example of this was the ISCHEMIA study. However, the benefits of functional lesion assessment, as demonstrated in the FAME studies, highlight the importance of this tool in guiding decisions regarding revascularization. Nevertheless, the clinical outcomes of patients<a href="https://solaci.org/en/2024/03/27/physiologically-significant-obstructions-in-the-left-main-coronary-artery-revascularizing-vs-deferring/" title="Read more" >...</a>

¿Es seguro utilizar iFR para diferir lesiones del tronco de la coronaria izquierda?

Rehospitalization After Treatment of Left Main Coronary Artery Disease and Its Prognosis: Sub-Analysis of the EXCEL Study

Individual randomized studies have shown variable results regarding the mortality risk following treatment of left main coronary artery disease (LMCAD), either through percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). However, upon assessment of the latest meta-analyses (with matched data), similar risks of all-cause and cardiovascular mortality have been reported for both groups.<a href="https://solaci.org/en/2024/03/21/rehospitalization-after-treatment-of-left-main-coronary-artery-disease-and-its-prognosis-sub-analysis-of-the-excel-study/" title="Read more" >...</a>

Se publicaron los resultados del estudio RESPECT con excelentes novedades

Lithotripsy in the Left Main Coronary Artery

A lesion ≥50% in the left main coronary artery (LMCA) is considered severe, according to various scientific societies, regardless of the presence of symptoms or ischemia, due to the extent of myocardium at risk. In such cases, revascularization is indicated. In many patients, lesions in this section of the coronary artery have severe calcification, which<a href="https://solaci.org/en/2024/03/13/lithotripsy-in-the-left-main-coronary-artery/" title="Read more" >...</a>

La ATC es una alternativa válida en el TCI

Use of Intravascular Lithotripsy in Left Main

The Left main coronary artery supplies circulation to roughly 70% of myocardium, and left main disease requires a high risk intervention with significant impact on patient prognosis. The current guidelines have set the threshold for intervention in LM disease at ≥50% stenosis, irrespective of the presence of symptoms or ischemic burden.&nbsp; LM calcification is an<a href="https://solaci.org/en/2024/02/27/use-of-intravascular-lithotripsy-in-left-main/" title="Read more" >...</a>

La ATC es una alternativa válida en el TCI

Revascularization vs. Deferral of Physiologically Significant Lesions in the Left Main Coronary Artery

Most randomized studies on decision-making in coronary artery disease revascularization exclude left main coronary artery disease (LMCAD), as did the ISCHEMIA Study. On the other hand, the benefits of functionally assessing lesions, proven in studies such as FAME, emphasize the importance of this tool in guiding revascularization decisions. However, there is still little understanding of<a href="https://solaci.org/en/2023/12/06/revascularization-vs-deferral-of-physiologically-significant-lesions-in-the-left-main-coronary-artery/" title="Read more" >...</a>

Watch Again Are You Ready for Left Main?

You can now relive our virtual event on Are You Ready for Left Main? on our YouTube channel. The event was held through the LATAM Bif-SOLACI Group, had the support of Terumo, and had the invaluable presence of Dr. Goran Stankovic (SRB), among other prominent experts from Latin America. Watch the full video below. &#x1f680;<a href="https://solaci.org/en/2023/09/21/watch-again-are-you-ready-for-left-main/" title="Read more" >...</a>

EuroPCR 2023 | Left Main Coronary Artery Angioplasty: One or Two Stents?

The EBC MAIN LM study randomized 467&nbsp;patients with severe left main coronary artery (LCA) lesions to receive provisional stenting or a two-sent strategy (Resolute or Onix stent). The two-stent strategy was decided by the operator (culotte, DK-minicrush, T/TAP). The crossover rate from those randomized to provisional stenting was 22%. After a 3-year follow-up, the composite<a href="https://solaci.org/en/2023/05/21/europcr-2023-left-main-coronary-artery-angioplasty-one-or-two-stents/" title="Read more" >...</a>

Top